Copyright 1998 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In 1993, Johns and colleagues1 described 2 monozygous twin brothers who had remained discordant for the development of Leber's hereditary optic neuropathy (LHON) for 6.5 years. Both brothers were found to harbor the identical homoplasmic 4216, 13708, and 11778 mitochondrial DNA mutations. Twin A developed bilateral optic neuropathy at the age of 34 years and had a visual acuity of 1/200 OU. At the time of the report, twin B was 41 years old and still had a visual acuity of 20/15 OU with no signs or symptoms of LHON. In this current report, updated information on twin B is provided and indicates that twin B has subsequently developed bilateral LHON.
Twin B, now 45 years old, had remained healthy and visually asymptomatic until he noted painless, blurred vision while driving on the morning of September 23, 1997. The visual loss first occurred in the left eye and then in the right eye 1 hour later. The patient reported no trauma, recent illness, weight change, or any unusual environmental exposure. He has continued to smoke 1 pack of cigarettes daily and to drink 24 beers weekly for the past 25 years. He was a firefighter but had not worked in this capacity for 2 years. He has been a part-time painter and has used latex paint for many years. His only medication was Ex-Lax twice a month for constipation since age 38. He has experienced much stress in the past year due to an ongoing litigation against his former employer for a nonphysically related matter. His daily activity has remained unchanged except for starting an exercise regimen 1 month prior to the visual loss. His typical routine was a 1-mile light run, 45 sit-ups, and 30 push-ups twice a week.
On examination, best visual acuity was count fingers at 4 inches OU. Pupillary reaction in both eyes was sluggish to light with no relative afferent pupillary defect. Goldmann perimetry demonstrated large central scotomas in both eyes. Intraocular pressures were 17 mm Hg OU. The optic nerves were hyperemic with a cup-disc ratio of 0.5 and no peripapillary vascular telangiectasia. The maculae and retinal vasculature appeared normal.
Updated information indicates that the discordance for LHON reported previously for a pair of monozygous twin brothers1 is temporal and not absolute. The discordance of the onset of LHON is 11 years, and the phenotypic findings are similar.
Potential mitigating factors such as excessive tobacco and alcohol use have been suggested in the phenotypic expression of LHON.2 - 4 In this case, both twins smoked 1 pack of cigarettes daily. However, twin A drank 6 to 12 beers weekly, which is less than half of the amount consumed by twin B who in fact had a much later onset of LHON. Both twins were firefighters, and twin A experienced visual loss 2 weeks after exposure to smoke. In contrast, twin B had not worked as a firefighter for 2 years and reported no recent exposure to smoke. The only recent change in his routine was starting a light exercise regimen 1 month prior to the visual loss. He did, however, report experiencing much stress for more than a year due to ongoing litigation. Interestingly, both twins noted the onset of visual loss while driving. However, this is a common activity and has not been associated with the onset of LHON.
In short, no common identifiable epigenetic factor for the clinical expression of LHON is apparent for these 2 monozygous twins who had a discordance for the onset of LHON of 11 years. This suggests that potential epigenetic factors for the clinical expression of LHON are variable and may be numerous.
Corresponding author: Byron L. Lam, MD, 900 NW 17th St, Miami, FL 33136.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Ophthalmology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.